These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2875505)

  • 1. [Value of serum beta 2-microglobulin in diabetes mellitus].
    Serban V; Deutsch G; Băcanu G
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(2):171-5. PubMed ID: 2875505
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beta 2 microglobulin in diabetic patients. Apropos of 190 subjects].
    Dauzat J; Moinade S; Gaillard G
    Sem Hop; 1984 Mar; 60(11):745-8. PubMed ID: 6324352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between beta 2 microglobulinemia and renal function in diabetes].
    Birch K; Hildebrandt P; Marshall MO; Sestoft L
    Ugeskr Laeger; 1984 Sep; 146(37):2773-5. PubMed ID: 6393497
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum beta 2 microglobulin assay in diabetes mellitus (author's transl)].
    Schlienger JL; Reiss D; Anceau A; Simon C; Stephan F
    Sem Hop; 1982 Apr; 58(16):959-62. PubMed ID: 6178166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of beta-2-microglobulin in diabetes mellitus].
    Tóth L; Szénási P; Varsányi NM; Szilvási I; Kammerer L
    Orv Hetil; 1989 Jan; 130(5):223-5. PubMed ID: 2644608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic nephropathy: has the time come to move beyond plasma creatinine?
    Osman MM; Ahmed MH
    Ren Fail; 2006; 28(6):525-6. PubMed ID: 16928625
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
    Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G
    J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.
    Mocan Z; Erem C; Yildirim M; Telatar M; Değer O
    Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta 2-microglobulin in the blood and urine in pyelonephritis in diabetes mellitus patients].
    Vasiukova EA; Turiev GS; Gerasimova NP; Ametov AS
    Med Radiol (Mosk); 1983 Nov; 28(11):59-63. PubMed ID: 6358761
    [No Abstract]   [Full Text] [Related]  

  • 10. A study of plasma C4 concentration and its possible association with microvascular complications in type I (insulin dependent) and type II (non-insulin dependent) diabetes.
    Arora S; Gauri LA; Saxena HC
    J Assoc Physicians India; 1988 Jul; 36(7):425-7. PubMed ID: 3204087
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
    Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of polypeptide analysis (beta-2-microglobulin, microalbuminuria, beta-thromboglobulin) in the diagnosis of diabetic nephropathies].
    Tóth L; Kammerer L
    Orv Hetil; 1992 Dec; 133(51):3237-41. PubMed ID: 1475108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of N-acetyl-glucosaminidase (NAG) in diabetic subjects].
    Melosi A; Ricci F
    Quad Sclavo Diagn; 1983 Mar; 19(1):113-20. PubMed ID: 6675040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Basal blood level of thyroxine in diabetes mellitus patients].
    Vakov L; Zakharieva B
    Vutr Boles; 1987; 26(1):60-5. PubMed ID: 3590731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of serum cystatin C in Japanese patients with type 2 diabetes mellitus and nephropathy.
    Kimura T; Ikeda H; Fujikawa J; Nomura K; Aoyama T; Wada Y; Nabe K; Hamamoto Y; Honjo S; Koshiyama H
    Diabetes Res Clin Pract; 2009 Feb; 83(2):e58-61. PubMed ID: 19118914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Basal blood level of serotonin in diabetes mellitus patients].
    Vakov L
    Vutr Boles; 1984; 23(1):79-84. PubMed ID: 6730455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of 3-deoxyglucosone, a potent protein crosslinking intermediate of Maillard reaction, in diabetic serum.
    Niwa T; Takeda N; Yoshizumi H; Tatematsu A; Ohara M; Tomiyama S; Niimura K
    Biochem Biophys Res Commun; 1993 Oct; 196(2):837-43. PubMed ID: 8240359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early detection of diabetic nephropathy: serum beta 2-microglobulin].
    Goebel FD; Schmeidl T; Füessl HS; Vogel S
    Klin Wochenschr; 1983 Dec; 61(23):1209-15. PubMed ID: 6361371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [N-acetyl-beta-D-glucosaminidase activity in relation to blood glucose, serum fructosamine and type I diabetic nephropathy].
    Pinto C; Fernandes F; Marques C; Silva A; Azevedo M; Lisboa P; Manso C
    Acta Med Port; 1985; 6(3-4):97-102. PubMed ID: 4025000
    [No Abstract]   [Full Text] [Related]  

  • 20. The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy.
    Lee BW; Ihm SH; Choi MG; Yoo HJ
    Diabetes Res Clin Pract; 2007 Dec; 78(3):428-34. PubMed ID: 17822797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.